Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditisDecember 16, 2022 at 12:26 PM EST
--News Direct--  Contact DetailsProactive Canada Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com View original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921 
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
